| [1] |
Leng F, Lin S, Wu W, et al. Epidemiology, pathogenetic mechanism, clinical characteristics, and treatment of Vibrio vulnificus infection: a case report and literature review[J]. Eur J Clin Microbiol Infect Dis, 2019, 38(11): 1999-2004.
|
| [2] |
Baker-Austin C, Oliver JD. Vibrio vulnificus: new insights into a deadly opportunistic pathogen[J]. Environ Microbiol, 2018, 20(2): 423-430.
|
| [3] |
Jones MK, Oliver JD. Vibrio vulnificus: disease and pathogenesis[J]. Infect Immun, 2009, 77(5): 1723-1733.
|
| [4] |
Oliver JD. The Biology of Vibrio vulnificus[J]. Microbiol Spectr, 2015, 3(3)．
|
| [5] |
洪广亮，卢才教，赵光举，等. 创伤弧菌脓毒症诊疗方案(2018)[J]. 中华急诊医学杂志，2018, 27(6): 594-598.
|
| [6] |
Chuang PY, Yang TY, Huang TW, et al. Hepatic disease and the risk of mortality of Vibrio vulnificus necrotizing skin and soft tissue infections: A systematic review and meta-analysis[J]. PLoS One, 2019, 14(10): e0223513.
|
| [7] |
高宇，应斌宇，郭蕾. 以皮肤损害为特征表现的创伤弧菌感染23例[J]. 中华皮肤科杂志，2010, 43(6): 374-377.
|
| [8] |
卢中秋，卢才教，洪广亮，等. 34例创伤弧菌脓毒症患者的流行病学特点及临床诊治[J]. 中华急诊医学杂志，2009, 18(7): 732-736.
|
| [9] |
Chao WN, Tsai CF, Chang HR, et al. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis[J]. Am J Surg, 2013, 206(1): 32-39.
|
| [10] |
卢才教，郭海雷，洪广亮，等. 早期外科手术治疗对肢体感染脓毒症的预后影响[J]. 中华创伤杂志，2012, 28(4): 321-323.
|
| [11] |
Kim BS, Kim JH, Choi S, et al. MARTX Toxin-Stimulated Interplay between Human Cells and Vibrio vulnificus[J]. mSphere, 2020, 5(4): e00659-20.
|
| [12] |
Jang SY, Hwang J, Kim BS, et al. Structural basis of inactivation of Ras and Rap1 small GTPases by Ras/Rap1-specific endopeptidase from the sepsis-causing pathogen Vibrio vulnificus[J]. J Biol Chem, 2018, 293(47): 18110-18122.
|
| [13] |
Gavin HE, Satchell KJF. RRSP and RID Effector Domains Dominate the Virulence Impact of Vibrio vulnificus MARTX Toxin[J]. J Infect Dis, 2019, 219(6): 889-897.
|
| [14] |
Horseman MA, Surani S. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection[J]. Int J Infect Dis, 2011, 15(3): e157-166.
|
| [15] |
Pettis GS, Mukerji AS. Structure, Function, and Regulation of the Essential Virulence Factor Capsular Polysaccharide of Vibrio vulnificus[J]. Int J Mol Sci, 2020, 21(9): 3259.
|
| [16] |
Kawasaki T, Kawai T. Toll-like receptor signaling pathways[J]. Front Immunol, 2014, 5: 461.
|
| [17] |
Çam S, Brinkmeyer R. Differential expression of vvhA and CPS operon allele 1 genes in Vibrio vulnificus under biofilm and planktonic conditions[J]. Antonie Van Leeuwenhoek, 2020, 113(10): 1437-1446.
|
| [18] |
Kim D, Na EJ, Kim JS, et al. Transcriptomic Identification and Biochemical Characterization of HmpA, a Nitric Oxide Dioxygenase, Essential for Pathogenesis of Vibrio vulnificus[J]. Front Microbiol, 2019, 10: 2208.
|
| [19] |
Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies[J]. Nat Rev Microbiol, 2004, 2(10): 820-832.
|
| [20] |
Lee A, Lim HX, Kim MS, et al. Vibrio vulnificus infection induces the maturation and activation of dendritic cells with inflammatory Th17-polarizing ability[J]. Int J Mol Med, 2018, 41(1): 531-540.
|
| [21] |
Atarashi K, Tanoue T, Ando M, et al. Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells[J]. Cell, 2015, 163(2): 367-380.
|
| [22] |
Shi Y, Liu XF, Zhuang Y, et al. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice[J]. J Immunol, 2010, 184(9): 5121-5129.
|
| [23] |
Cooper AM. IL-23 and IL-17 have a multi-faceted largely negative role in fungal infection[J]. Eur J Immunol, 2007, 37(10): 2680-2682.
|
| [24] |
Flierl MA, Rittirsch D, Gao H, et al. Adverse functions of IL-17A in experimental sepsis[J]. FASEB J, 2008, 22(7): 2198-2205.
|
| [25] |
Yuan Y, Feng Z, Wang J. Vibrio vulnificus Hemolysin: Biological Activity, Regulation of vvhA Expression, and Role in Pathogenesis[J]. Front Immunol, 2020, 11: 599439.
|
| [26] |
Choi G, Jang KK, Lim JG, et al. The transcriptional regulator IscR integrates host-derived nitrosative stress and iron starvation in activation of the vvhBA operon in Vibrio vulnificus[J]. J Biol Chem, 2020, 295(16): 5350-5361.
|
| [27] |
Kawase T, Miura F, Debnath A, et al. Functional analysis of N-terminal propeptide in the precursor of Vibrio vulnificus metalloprotease by using cell-free translational system[J]. Protein Expr Purif, 2018, 149: 13-16.
|
| [28] |
Kim JA, Lee MA, Jung YC, et al. Repression of VvpM Protease Expression by Quorum Sensing and the cAMP-cAMP Receptor Protein Complex in Vibrio vulnificus[J]. J Bacteriol, 2018, 200(7): e00526-17.
|
| [29] |
Lee MA, Kim JA, Yang YJ, et al. VvpM, an extracellular metalloprotease of Vibrio vulnificus, induces apoptotic death of human cells[J]. J Microbiol, 2014, 52(12): 1036-1043.
|
| [30] |
Guo RH, Lim JY, Tra My DN, et al. Vibrio vulnificus RtxA1 Toxin Expression Upon Contact With Host Cells Is RpoS-Dependent[J]. Front Cell Infect Microbiol, 2018, 8: 70.
|
| [31] |
Kim BA, Lim JY, Rhee JH, et al. Characterization of Prohibitin 1 as a Host Partner of Vibrio vulnificus RtxA1 Toxin[J]. J Infect Dis, 2016, 213(1): 131-138.
|
| [32] |
Lee TH, Kim MH, Lee CS, et al. Protection against Vibrio vulnificus infection by active and passive immunization with the C-terminal region of the RtxA1/MARTXVv protein[J]. Vaccine, 2014, 32(2): 271-276.
|
| [33] |
Lo HR, Lin JH, Chen YH, et al. RTX toxin enhances the survival of Vibrio vulnificus during infection by protecting the organism from phagocytosis[J]. J Infect Dis, 2011, 203(12): 1866-1874.
|
| [34] |
Kuo SY, Chou MC, Lee SL, et al. Vibrio vulnificus RtxA1 modulated calcium flux contributes reduced internalization in phagocytes[J]. Life Sci, 2015, 132: 55-60.
|
| [35] |
Guo RH, Im YJ, Shin SI, et al. Vibrio vulnificus RtxA1 cytotoxin targets filamin A to regulate PAK1- and MAPK-dependent cytoskeleton reorganization and cell death[J]. Emerg Microbes Infect, 2019, 8(1): 934-945.
|
| [36] |
Datta S, Kenton RJ. Characterization of temperature-dependent hemin uptake receptors HupA and HvtA in Vibrio vulnificus[J]. Microbiologyopen, 2019, 8(10): e905.
|
| [37] |
Yun NR, Kim DM. Vibrio vulnificus infection: a persistent threat to public health[J]. Korean J Intern Med, 2018, 33(6): 1070-1078.
|
| [38] |
Starks AM, Bourdage KL, Thiaville PC, et al. Use of a marker plasmid to examine differential rates of growth and death between clinical and environmental strains of Vibrio vulnificus in experimentally infected mice[J]. Mol Microbiol, 2006, 61(2): 310-323.
|
| [39] |
Okai N, Miyamoto K, Tomoo K, et al. VuuB and IutB reduce ferric-vulnibactin in Vibrio vulnificus M2799[J]. Biometals, 2020, 33(4/5): 187-200.
|
| [40] |
Abisado RG, Benomar S, Klaus JR, et al. Bacterial Quorum Sensing and Microbial Community Interactions[J]. mBio, 2018, 9(3): e02331-17.
|
| [41] |
Lee W, Lee SH, Kim M, et al. Vibrio vulnificus quorum-sensing molecule cyclo(Phe-Pro) inhibits RIG-I-mediated antiviral innate immunity[J]. Nat Commun, 2018, 9(1): 1606.
|
| [42] |
Kim IH, Kim SY, Park NY, et al. Cyclo-(l-Phe-l-Pro), a Quorum-Sensing Signal of Vibrio vulnificus, Induces Expression of Hydroperoxidase through a ToxR-LeuO-HU-RpoS Signaling Pathway To Confer Resistance against Oxidative Stress[J]. Infect Immun, 2018, 86(9): e00932-17.
|